Atlas Trials

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Clinical trial NCT05487040 · TERMINATED

Trial details

NCT number
NCT05487040
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2022-09-07
Primary completion
2023-07-11
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.